Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

STIM

Neuronetics Inc

Dec 01 • 04:00PM ET

2.03

Dollar change +0.21
Percentage change 11.54	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	10.18%	Shs Outstand	27.27M	Perf Week	40.00%
Market Cap	58.73M	Forward P/E	-	EPS next Y	-0.95	Insider Trans	-0.85%	Shs Float	25.99M	Perf Month	76.52%
Income	-33.10M	PEG	-	EPS next Q	-0.26	Inst Own	65.55%	Short Float / Ratio	1.41% / 4.71	Perf Quarter	24.54%
Sales	69.23M	P/S	0.85	EPS this Y	17.80%	Inst Trans	-2.28%	Short Interest	0.37M	Perf Half Y	-25.09%
Book/sh	1.31	P/B	1.55	EPS next Y	15.95%	ROA	-31.20%	Target Price	6.00	Perf Year	-67.68%
Cash/sh	1.27	P/C	1.60	EPS next 5Y	-	ROE	-65.59%	52W Range	1.03 - 6.95	Perf YTD	-70.45%
Dividend	-	P/FCF	-	EPS past 5Y	-8.61%	ROI	-42.82%	52W High	-70.80%	Beta	2.03
Dividend %	-	Quick Ratio	4.00	Sales past 5Y	11.61%	Gross Margin	68.80%	52W Low	97.09%	ATR	0.13
Employees	194	Current Ratio	4.63	Sales Q/Q	8.40%	Oper. Margin	-48.18%	RSI (14)	79.92	Volatility	13.20% 10.23%
Optionable	Yes	Debt/Eq	1.06	EPS Q/Q	-15.24%	Profit Margin	-47.81%	Rel Volume	2.29	Prev Close	1.82
Shortable	Yes	LT Debt/Eq	1.04	Earnings	Nov 07 BMO	Payout	-	Avg Volume	77.92K	Price	2.03
Recom	1.50	SMA20	47.37%	SMA50	61.11%	SMA200	-8.72%	Volume	178,670	Change	11.54%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Nov-15-23 04:15PM	Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:57AM	NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements (GlobeNewswire)
Nov-09-23 08:32AM	Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage (GlobeNewswire) -11.30%
Nov-08-23 01:16PM	Neuronetics, Inc. (NASDAQ:STIM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:57AM	Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 (GuruFocus.com) +8.11%
07:43AM	Loading…
07:43AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Nov-06-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.50%
Oct-24-23 08:30AM	Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Oct-16-23 08:56AM	Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes (GlobeNewswire)
Oct-03-23 09:21AM	Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility (GlobeNewswire) -6.87%
Sep-12-23 08:56AM	In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression (GlobeNewswire)
Aug-21-23 08:56AM	NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards (GlobeNewswire)
Aug-18-23 09:02PM	Cannell Capital LLC Reduces Stake in Neuronetics Inc (GuruFocus.com)
Aug-14-23 09:02AM	Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform (GlobeNewswire)
12:00PM	Loading…
Aug-11-23 12:00PM	Neuronetics (STIM) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-08-23 08:22AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results (GlobeNewswire)
Aug-04-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-23 08:30AM	Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-19-23 08:56AM	Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans (GlobeNewswire)
Jul-17-23 08:46AM	NeuroStar Achieves Milestone Regulatory Clearance in South Korea (GlobeNewswire)
Jul-11-23 08:56AM	NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player (GlobeNewswire)
Jun-12-23 11:25AM	Abbott (ABT) EPD Sales Gain Traction, Margin Pressure Lingers (Zacks)
11:18AM	LabCorp (LH) Gives Update as Fortrea Spinoff Nears Closure (Zacks)
08:59AM	Neuronetics Receives 510(k) Clearance for OCD MT Cap for NeuroStar Advanced Therapy (GlobeNewswire)
Jun-09-23 09:50AM	Illumina (ILMN) Sequencing Arm Grows, Margin Woes Linger (Zacks)
08:53AM	Charles River (CRL) to Aid INADcure in Plasmid DNA Manufacture (Zacks)
Jun-08-23 12:18PM	Neuronetics, Inc. (NASDAQ:STIM) Could Be Riskier Than It Looks (Simply Wall St.)
09:31AM	Bruker (BRKR) Launches timsTOF Ultra Mass Spec and VistaScan (Zacks)
11:19AM	Loading…
Jun-06-23 11:19AM	Quest Diagnostics' (DGX) Contract Wins Aid Amid Volume Woes (Zacks)
08:04AM	Bruker's (BRKR) Latest Workflows to Aid Applied Markets (Zacks)
Jun-02-23 10:26AM	Walgreens Boots (WBA) Gains From New Alliances Amid Macro Woes (Zacks)
08:33AM	Neogen (NEOG) Introduces 2 Assays for Histamine Detection (Zacks)
Jun-01-23 08:39AM	LabCorp (LH) Expands Precision Oncology With Biopsy Test (Zacks)
May-31-23 09:16AM	Illumina (ILMN) to Present Real-World CGP Data at ASCO Meet '23 (Zacks)
May-30-23 01:50PM	Neuronetics investing in NeuroStar awareness as drug-free treatment alternative for depression (News Direct) -5.14%
May-29-23 02:06AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Revised) (Zacks)
May-26-23 08:59AM	Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan (GlobeNewswire) +6.18%
May-25-23 12:25PM	Myriad Genetics (MYGN) Adds New Test to Oncology Portfolio (Zacks)
May-24-23 04:30PM	Neuronetics to Present at the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
09:34AM	Medtronic's (MDT) EV ICD Pivotal Study Shows Favorable Outcome (Zacks)
May-23-23 10:10AM	Exact Sciences (EXAS) Gains From New Buyouts Amid High Costs (Zacks)
08:46AM	New Depression Barometer Survey Shows Patients Are Stopping Treatment Due to Dissatisfaction (GlobeNewswire)
May-22-23 08:01AM	Thermo Fisher (TMO) Gets FDA Clearance for Its Immunoassays (Zacks)
May-18-23 10:16AM	Illumina (ILMN) Progresses in Pathogen Genomic Technologies (Zacks) -6.88%
May-17-23 11:09AM	Hologic (HOLX) Announces Collaboration With NFL CB Kelee Ringo (Zacks)
May-15-23 08:56AM	Neuronetics Wins 2023 Bell Seal for Workplace Mental Health (GlobeNewswire)
07:58AM	Integra (IART) Builds Advanced R&D Facility in New Jersey (Zacks)
May-09-23 05:00PM	Neuronetics to Present at the JMP Securities Life Sciences Conference (GlobeNewswire) +27.27%
08:55AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Neuronetics Reports Record First Quarter 2023 Financial and Operating Results (GlobeNewswire)
May-08-23 08:47AM	Neuronetics Receives MDSAP Certification and CE Mark Certification under New MDR (GlobeNewswire)
May-05-23 08:30AM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-03-23 08:58AM	Neuronetics Showcases New NeuroStar® TMS Findings at Clinical TMS Society Annual Meeting (GlobeNewswire)
May-02-23 09:01AM	NeuroStar® Expands Tap Into Possibility Campaign in Honor of Mental Health Awareness Month (GlobeNewswire)
May-01-23 08:46AM	Neuronetics Announces Lisa Metzner-Rosas as SVP, Chief Marketing Officer (GlobeNewswire)
Apr-28-23 04:11PM	Neuronetics Announces Expanded TMS Access through United HealthCare (GlobeNewswire)
Apr-25-23 08:30AM	Neuronetics to Report First Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-18-23 02:14PM	Further weakness as Neuronetics (NASDAQ:STIM) drops 11% this week, taking one-year losses to 25% (Simply Wall St.)
Apr-13-23 08:58AM	Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy (GlobeNewswire)
Apr-06-23 04:16PM	NeuroStar® Advanced Therapy Enhanced With Wi-Fi Capabilities (GlobeNewswire) -9.38%
Apr-04-23 08:30AM	Neuronetics Secures Up To $60 Million in New Debt Financing with SLR Capital Partners, Provides Greenbrook TMS with $6.0 Million Promissory Note (GlobeNewswire)
Mar-16-23 08:56AM	NeuroStar® Advanced Therapy Receives Patient Impact Award from Life Sciences PA (GlobeNewswire)
Mar-08-23 10:02PM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.93%
12:44AM	Q4 2022 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 08:45AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -19.19%
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results (GlobeNewswire)
Mar-02-23 04:02PM	Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives (GlobeNewswire) -5.26%
Feb-27-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Feb-23-23 08:56AM	Neuronetics Expands NeuroStar® Advanced Therapys Proprietary TrakStar® Platform (GlobeNewswire) -10.02%
Feb-22-23 04:35PM	Neuronetics to Report Fourth Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-21-23 08:53AM	Neuronetics Sponsors the 5th International Brain Stimulation Conference (GlobeNewswire)
Feb-16-23 04:12PM	Neuronetics Announces Elevation of Sara Grubbs to SVP, Chief Revenue Officer (GlobeNewswire)
Feb-10-23 04:15PM	Neuronetics Announces Updated Medicare Policy Expanding Access to NeuroStar TMS Therapy through Nurse Practitioners (GlobeNewswire)
Jan-19-23 10:50AM	Neuronetics Inks Six-Year Exclusive Partnership With Greenbrook TMS (Benzinga)
08:30AM	Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership (GlobeNewswire)
Jan-18-23 04:29PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -5.35%
Jan-17-23 08:32AM	Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health (GlobeNewswire)
Jan-10-23 12:27PM	Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay (Benzinga)
08:00AM	Neuronetics Settles Litigation Against BrainsWay (GlobeNewswire)
Jan-09-23 08:30AM	Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire)
Dec-29-22 04:29PM	Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors (GlobeNewswire)
Dec-27-22 09:04AM	5 Winning Medical Product Stocks That Still Have Room to Run (Zacks)
Dec-23-22 09:40AM	Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year? (Zacks)
Dec-22-22 06:42AM	Owning 50% shares,institutional owners seem interested in Neuronetics, Inc. (NASDAQ:STIM), (Simply Wall St.)
Dec-07-22 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-06-22 12:00PM	Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know (Zacks)
Dec-05-22 08:32AM	Neuronetics Announced as a Winner by 2022 Merit Awards for HealthCare in the Patient Care Category (GlobeNewswire)
Nov-21-22 04:30PM	Neuronetics to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) -6.23%
Nov-14-22 08:33AM	Neuronetics Announces NeuroStar® Advanced Therapy for Mental Health System Innovations (GlobeNewswire)
Nov-10-22 09:48AM	Neuronetics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.) +7.50%
Nov-09-22 08:04PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.53%
09:46AM	The past year for Neuronetics (NASDAQ:STIM) investors has not been profitable (Simply Wall St.)
Nov-08-22 08:45AM	Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Neuronetics Reports Third Quarter 2022 Financial and Operating Results (GlobeNewswire)
Oct-31-22 08:31AM	Neuronetics Announced as Winner by 2022 Merit Awards for Technology (GlobeNewswire)
Oct-25-22 10:31AM	Neuronetics Announces Updated TMS Coverage Policies That Will Expand Patient Access to NeuroStar TMS Therapy for Mental Health (GlobeNewswire)
08:30AM	Neuronetics to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Sep-26-22 08:31AM	Neuronetics Launches Innovations To NeuroStar® Advanced Therapys Proprietary TrakStar® Platform (GlobeNewswire)

Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Furlong Stephen	EVP, CFO and Treasurer	Oct 06	Sale	1.16	1,499	1,731	429,556	Oct 10 05:10 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Oct 06	Sale	1.16	1,469	1,697	383,733	Oct 10 05:12 PM
Sullivan Keith J	President and CEO	Jul 21	Sale	2.04	6,551	13,364	1,177,658	Jul 25 07:50 PM
Sullivan Keith J	President and CEO	Jul 20	Sale	2.06	6,510	13,411	1,184,209	Jul 21 06:15 PM
Sullivan Keith J	President and CEO	Jul 19	Sale	2.07	6,479	13,412	1,190,719	Jul 21 06:15 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Jul 11	Sale	2.13	2,645	5,634	385,202	Jul 12 08:35 PM
BAKEWELL JOHN K	Director	May 24	Sale	2.70	14,400	38,880	77,988	May 26 04:10 PM
CANNELL CAPITAL LLC	10% Owner	Mar 17	Buy	2.89	7,644	22,091	3,127,819	Mar 20 07:40 PM
CANNELL CAPITAL LLC	10% Owner	Mar 16	Buy	2.90	52,072	151,009	3,120,175	Mar 20 07:40 PM
CANNELL CAPITAL LLC	10% Owner	Mar 13	Buy	2.97	136,520	405,464	3,068,103	Mar 15 05:25 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Mar 07	Sale	4.59	12,692	58,256	387,847	Mar 09 04:09 PM
Furlong Stephen	EVP, CFO and Treasurer	Mar 07	Sale	4.59	11,079	50,853	431,055	Mar 09 04:08 PM
CANNELL CAPITAL LLC	10% Owner	Mar 07	Sale	4.71	7,746	36,484	2,931,583	Mar 09 05:43 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 16	Sale	5.91	11,044	65,270	400,539	Feb 17 04:45 PM
Furlong Stephen	CFO	Feb 15	Sale	5.90	13,148	77,573	442,134	Feb 16 05:17 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 15	Sale	5.90	11,974	70,647	411,583	Feb 17 04:45 PM
Sullivan Keith J	President and CEO	Feb 14	Sale	5.58	13,647	76,150	1,197,198	Feb 15 04:43 PM
Furlong Stephen	CFO	Feb 14	Sale	5.58	12,403	69,209	455,282	Feb 16 05:17 PM
Sullivan Keith J	President and CEO	Feb 13	Sale	5.49	25,154	138,095	1,210,845	Feb 15 04:43 PM
Furlong Stephen	CFO	Feb 07	Sale	5.99	5,584	33,448	367,685	Feb 09 05:43 PM
MACAN WILLIAM ANDREW	SVP and General Counsel	Feb 07	Sale	5.99	5,162	30,920	333,557	Feb 09 05:48 PM
MACAN WILLIAM ANDREW	SVP and General Counsel	Jan 23	Sale	5.96	16,046	95,634	338,719	Jan 24 04:09 PM
Furlong Stephen	CFO	Jan 17	Sale	6.13	16,050	98,386	373,269	Jan 18 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Jan 17	Sale	6.31	2,912	18,375	2,939,329	Jan 19 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 13	Sale	6.30	4,896	30,845	2,942,241	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 12	Sale	6.30	12,397	78,101	2,947,137	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 11	Sale	6.45	8,970	57,856	2,959,534	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 10	Sale	6.68	36,885	246,392	2,968,504	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 09	Sale	6.59	141,664	933,566	3,005,389	Jan 13 05:32 PM
CANNELL CAPITAL LLC	10% Owner	Jan 06	Sale	6.61	25,937	171,444	3,147,053	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 05	Sale	6.29	33,267	209,249	3,172,990	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 04	Sale	6.73	23,434	157,711	3,206,257	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Jan 03	Sale	6.66	16,440	109,490	3,299,691	Jan 06 05:07 PM
CANNELL CAPITAL LLC	10% Owner	Dec 27	Sale	6.01	6,161	37,028	3,246,131	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 23	Sale	6.02	6,513	39,208	3,252,292	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 22	Sale	6.11	1,500	9,165	3,258,805	Dec 27 04:58 PM
CANNELL CAPITAL LLC	10% Owner	Dec 21	Sale	6.31	7,311	46,132	3,260,305	Dec 21 05:49 PM
CANNELL CAPITAL LLC	10% Owner	Dec 20	Sale	6.30	183,198	1,154,147	3,267,616	Dec 21 05:49 PM
CANNELL CAPITAL LLC	10% Owner	Dec 19	Sale	6.35	13,032	82,753	3,450,814	Dec 21 05:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM

Neuronetics Inc

Upgrade your FINVIZ experience